Jennifer (Jen) Pardi, MBA was appointed Global Head of Equity Capital Markets in October 2020 and is responsible for oversight of Canaccord Genuity’s global ECM activities, with a focus on driving coordination and best practices across all regions to drive optimal outcomes for our corporate and institutional clients.
Jen joined Adams Harkness (acquired by Canaccord in 2005) in 2003. She has held roles of increasing responsibility within the U.S. ECM team and has been integral to increasing CG’s U.S. syndicate participation and subsequent advancement to a top-ranked midmarket investment dealer in the region. She was promoted to Head of U.S. Equity Capital Markets in September 2013. With extensive corporate finance, equity and debt capital markets experience, Jen has been at the forefront of Canaccord Genuity’s cross-border equity capital markets activities and has been involved in the completion of over 1,000 transactions with an aggregate value of over $150 billion.
Based in Boston, Jen also serves on Canaccord Genuity’s U.S. Operating Committee. She has been a significant contributor to CG’s firmwide diversity initiatives, with a strong focus on increasing opportunities for women entering the capital markets, in addition to driving CG’s participation in various local community and charitable initiatives.
Selected Transactions
-
US$28mBrazil Potash
Lead Placement Agent (Private Placement)
-
US$55mDragonfly Energy
Sole Bookrunner (Follow-On Offering)
-
US$29mDragonfly Energy
Sole Bookrunner (Registered Direct Offering)
-
US$50mContango Ore
Sole Bookrunner (Registered Direct Offering)
-
US$29mLucid Diagnostics
Joint Bookrunner (Follow-On Offering)
-
US$60mASP Isotopes
Joint Bookrunner (Registered Direct Offering)
-
US$175mRhythm Pharmaceuticals
Lead Manager (Follow-On Offering)
-
US$50mASP Isotopes
Joint Bookrunner (Registered Direct Offering)
-
US$600mGalaxy Digital
Joint Bookrunner (Upsized Offering of Common Stock)